Sotac Pharmaceuticals Limited (NSE: SOTAC)
India flag India · Delayed Price · Currency is INR
109.50
-5.40 (-4.70%)
At close: Dec 20, 2024

Sotac Pharmaceuticals Company Description

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.

Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin.

The company also offers beta and non-beta‐lactam tablets; beta and non-beta‐lactam capsules; oral liquids; dry syrups; and external preparations, such as nasal sprays, relief sprays, and creams.

In addition, it is involved in the research of pharmaceutical molecules used in developing new pharmaceutical formulations; and manufacture of nutraceuticals medicinal and food products.

The company also exports its products. Sotac Pharmaceuticals Limited was founded in 2014 and is based in Ahmedabad, India.

Sotac Pharmaceuticals Limited
Country India
Founded 2014
Industry Pharmaceutical Preparations
Employees 68
CEO Sharadkumar Patel

Contact Details

Address:
Plot No. PF-21
Ahmedabad, 382110
India
Phone 91 99 1356 2852
Website sotacpharma.com

Stock Details

Ticker Symbol SOTAC
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Sharadkumar Patel Chief Executive Officer
Brijeshkumar Patel Chief Financial Officer